Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (32)

2024

  1. Efficacy of a benzothiazole-based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis

    CNS Neuroscience and Therapeutics, Vol. 30, Núm. 1

2023

  1. Editorial: Advanced technologies in bioengineering to fight antimicrobial resistance

    Frontiers in Bioengineering and Biotechnology

  2. Modulation of taxane binding to tubulin curved and straight conformations by systematic 3′N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potency

    European Journal of Medicinal Chemistry, Vol. 259

  3. Structural insight into the stabilization of microtubules by taxanes

    eLife, Vol. 12

2022

  1. Strain-specific predation of Bdellovibrio bacteriovorus on Pseudomonas aeruginosa with a higher range for cystic fibrosis than for bacteremia isolates

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Synthesis of N-acyl derivatives of aminocombretastatin A-4 and study of their interaction with tubulin and downregulation of c-Myc

    Medicinal Chemistry, Vol. 17, Núm. 10, pp. 1129-1139

2020

  1. Structural model for differential cap maturation at growing microtubule ends

    eLife, Vol. 9

2019

  1. Klebsiella oxytoca enterotoxins tilimycin and tilivalline have distinct host DNA-damaging and microtubule-stabilizing activities

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3774-3783

2018

  1. Medical nutrition therapy for gestational diabetes mellitus based on Mediterranean Diet principles: A subanalysis of the St Carlos GDM Prevention Study

    BMJ Open Diabetes Research and Care, Vol. 6, Núm. 1

2017

  1. Enterocin AS-48 as evidence for the use of bacteriocins as new leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 4

  2. Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Snail1-dependent activation of cancer-associated fibroblast controls epithelial tumor cell invasion and metastasis

    Cancer Research, Vol. 76, Núm. 21, pp. 6205-6217

  2. Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI)

    Oncogene, Vol. 35, Núm. 40, pp. 5224-5236

2015

  1. LOXL2 is highly expressed in cancer-associated fibroblasts and associates to poor colon cancer survival

    Clinical Cancer Research, Vol. 21, Núm. 21, pp. 4892-4902

2014

  1. Protumorigenic effects of Snail-expression fibroblasts on colon cancer cells

    International Journal of Cancer, Vol. 134, Núm. 12, pp. 2984-2990

2013

  1. Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients

    Cancer Science, Vol. 104, Núm. 4, pp. 437-444

  2. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature

    Clinical Cancer Research, Vol. 19, Núm. 21, pp. 5914-5926

  3. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer

    Clinical Cancer Research, Vol. 19, Núm. 21, pp. 6006-6019

2008

  1. Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania

    FASEB Journal, Vol. 22, Núm. 6, pp. 1817-1828

  2. The evolution of contact-dependent inhibition in non-growing populations of Escherichia coli

    Proceedings of the Royal Society B: Biological Sciences, Vol. 275, Núm. 1630, pp. 3-10